Summary

Eli Lilly and Company (NYSE: LLY ) is one of the 13 Best Extremely Profitable Stocks to Invest in Now . On February 2, 2026, Reuters reported that long-standing expectations that the global obesity drug market would reach $150 billion over the next decade are being reconsidered amid declining U.S. prices for GLP-1 therapies and intensifying competition. The new projections indicate that the market will reach closer to $100 billion by 2030, which is roughly 30% less than previous estimates.

AI summaries can be wrong sometimes—always verify important details using the source article.